Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
Universidade de Lisboa
Lisboa, PortugalPublicacións en colaboración con investigadores/as de Universidade de Lisboa (87)
2024
-
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287
-
Brain function in classic galactosemia, a galactosemia network (GalNet) members review
Frontiers in Genetics
-
Ferritin heavy chain supports stability and function of the regulatory T cell lineage
EMBO Journal, Vol. 43, Núm. 8, pp. 1445-1483
2023
-
Addressing influenza’s underestimated burden – Iberian experts call to action
BMC Infectious Diseases
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
Nutrients, Vol. 15, Núm. 18
-
Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update
Drug Safety, Vol. 46, Núm. 7, pp. 625-636
-
Factors associated with underreporting of adverse drug reactions by patients: a systematic review
International Journal of Clinical Pharmacy, Vol. 45, Núm. 6, pp. 1349-1358
-
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901
-
Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study
Revista Portuguesa de Cardiologia, Vol. 42, Núm. 12, pp. 985-995
2022
-
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978
-
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
The Lancet Rheumatology, Vol. 4, Núm. 9, pp. e603-e613
-
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
The Lancet, Vol. 399, Núm. 10340, pp. 2047-2064
-
Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach
Molecular Genetics and Metabolism, Vol. 137, Núm. 1-2, pp. 114-126
-
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
Arthritis Care and Research, Vol. 74, Núm. 7, pp. 1205-1218
-
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
European Urology Open Science, Vol. 45, pp. 12-22
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
European Respiratory Journal
-
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Rheumatology (Oxford, England), Vol. 61, Núm. 12, pp. 4741-4751